CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice
Nae-Yun Heo, Young-Suk Lim, Han Chu Lee, Yung Sang Lee, Kang Mo Kim, Kwan Soo Byun, Kwang-Hyub Han, Kwan Sik Lee, Seung Woon Paik, Seung Kew Yoon, Dong Jin Suh
Clin Mol Hepatol. 2013;19(1):60-69.   Published online 2013 March 25    DOI: https://doi.org/10.3350/cmh.2013.19.1.60

Excel Download

W1017 Clinical and Persistency Outcomes in Hepatitis C Patients Treated with Peginterferon Alfa-2a or Peginterferon Alfa-2b Plus Ribavirin
Gastroenterology. 2008;134(4):A-833   Crossref logo
Link1 Link2

P17: Responses to peginterferon alfa-2a versus alfa-2b plus ribavirin in a Mexican population with chronic hepatitis C
Journal of Viral Hepatitis. 2013;20:25-25   Crossref logo
Link1

High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice
Clinical and Molecular Hepatology. 2013;19(1):60   Crossref logo
Link1 Link2

Peginterferon alfa-2A (40KD) (PEGASYS) plus ribavirin (RBV) and amantadine (AMA) vs induction therapy with interferon alfa-2A (roferon-A) plus RBV and AMA in IFN/RBV nonresponder patients with chronic hepatitis C (CHC)
Journal of Hepatology. 2003;38:139-140   Crossref logo
Link1 Link2

252 Randomized controlled trial of PEGinterferon alfa-2A plus ribavirin for chronic hepatitis C virus-genotype 4 among Egyptian patients
Hepatology. 2003;38:278-278   Crossref logo
Link1 Link2

PIN31: THE COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A (40KD) (PEGASYS) PLUS RIBAVIRIN (COPEGUS) VS. INTERFERON ALFA-2B PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C (CHC)
Value in Health. 2003;6(3):262-263   Crossref logo
Link1 Link2

PIN19 A COMPARISON OF COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A (40KD) (PEGASYS) PLUS RIBAVIRIN (COPEGUS) VERSUS INTERFERON ALFA-2B PLUS RIBAVIRIN AS FIRST TREATMENT OF CHRONIC HEPATITIS C IN THE UK
Value in Health. 2004;7(6):763-764   Crossref logo
Link1 Link2

Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin
Alimentary Pharmacology & Therapeutics. 2007;27(5):433-440   Crossref logo
Link1

Peginterferon Alfa-2a Plus Ribavirin Is More Effective Than Peginterferon Alfa-2b Plus Ribavirin for Treating Chronic Hepatitis C Virus Infection
Gastroenterology. 2010;138(1):116-122   Crossref logo
Link1 Link2

475 Sustained virological response (SVR) to peginterferon alfa-2A (40KD) (PEGASYS) plus ribavirin (RBV) and amantadine (AMA) vs induction therapy with interferon alfa-2A (Roferon-A) plus RBV and AMA in IFN/RBV non responders (NR) with chronic hepatitis C (CHC)
Journal of Hepatology. 2004;40:140   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.